Integrated Research (IRI) Trading Update summary

Financial performance and trading update

• Anticipated total contract value (TCV) for 1H FY25 is $23.0m–$27.0m, down 39% (midpoint) from the prior period.

• New business TCV is expected at $7.5m–$9.5m, up 87% (midpoint) versus the prior period.

• Revenue for 1H FY25 is forecast at $25.0m–$29.0m, a 34% decrease (midpoint) from the prior period.

• EBITDA is projected between $(0.5m) and $2.0m, a 93% decrease (midpoint) from the prior period.

• Renewal contract value is softer in 1H FY25 but expected to be significantly stronger in 2H FY25.

Strategic initiatives and outlook

• Product-led growth strategy focuses on increasing new business TCV and developing new products.

• Increased investment is being made to enhance product capabilities and support medium-term growth.

• CEO highlights confidence in new product investment as a foundation for sustainable growth.

• Announcements regarding new product releases are expected in the coming months.

Company background

• Integrated Research provides user experience and performance management solutions for payment and collaboration systems.

• The company leverages a hybrid cloud platform and deep domain expertise to optimize mission-critical operations.

• Solutions are used by many of the world’s largest organizations to ensure operational visibility and reliability.